Clinical Trial

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-12-19; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2019-02-18
Trial Details
NCT Number NCT03384563
Lead Sponsor Baylor College of Medicine
Conditions Pediatric Anesthesia
Enrollment 180 participants
Start Date 2018-02-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-22